Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :24027284
Publication Date : //

Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.


Burst firing has been reported as a pathological activity of subthalamic nucleus (STN) neurons in Parkinson's disease. However, the origin of bursts and their causal link with motor deficits remain unknown. Here we tested the hypothesis that dopamine D5 receptors (D5Rs), characterized by a high constitutive activity, may contribute to the emergence of burst firing in STN. We tested whether inhibiting D5R constitutive activity depresses burst firing and alleviates motor impairments in the 6-OHDA rat model of Parkinson's disease. Intrasubthalamic microinjections of either an inverse agonist of D5Rs, flupenthixol, or a D2R antagonist, raclopride, were applied. Behavioral experiments, in vivo and in vitro electrophysiological recordings, and ex vivo functional neuroanatomy studies were performed. Using [(5)S]GTPγ binding autoradiography, we show that application of flupenthixol inhibits D5R constitutive activity within the STN. Furthermore, flupenthixol reduced evoked burst in brain slices and converted pathological burst firing into physiological tonic, single-spike firing in 6-OHDA rats in vivo. This later action was mimicked by calciseptine, a Cav1 channel blocker. Moreover, the same treatment dramatically attenuated motor impairment in this model and normalized metabolic hyperactivity in both STN and substantia nigra pars reticulata, the main output structure of basal ganglia in rats. In contrast, raclopride as well as saline did not reverse burst firing and motor deficits, confirming the selective action of flupenthixol on D5Rs. These results are the first to demonstrate that subthalamic D5Rs are involved in the pathophysiology of Parkinson's disease and that administering an inverse agonist of these receptors may lessen motor symptoms.

Authors : Chetrit Jonathan , Taupignon Anne , Froux Lionel , Morin Stephanie , Bouali-Benazzouz Rabia , Naudet Frédéric , Kadiri Nabila , Gross Christian E , Bioulac Bernard , Benazzouz Abdelhamid ,

Related products :

Catalog number Product name Quantity
EIAAB33735 Calcitonin-receptor-like receptor activity-modifying protein 3,CRLR activity-modifying protein 3,Homo sapiens,Human,RAMP3,Receptor activity-modifying protein 3
EIAAB33727 Calcitonin-receptor-like receptor activity-modifying protein 1,CRLR activity-modifying protein 1,Homo sapiens,Human,RAMP1,Receptor activity-modifying protein 1
EIAAB33730 Calcitonin-receptor-like receptor activity-modifying protein 2,CRLR activity-modifying protein 2,Homo sapiens,Human,RAMP2,Receptor activity-modifying protein 2
30-276 GDE1 has glycerophosphoinositol phosphodiesterase activity. It has little or no activity towards glycerophosphocholine. GDE1 activity can be modulated by G-protein signaling pathways. 0.05 mg
285 COAGULATION ACTIVITY INHIBITING 'C' PROTEIN, PLASMA 1
286 COAGULATION ACTIVITY INHIBITING 'S' PROTEIN, PLASMA 1
E13720h Human G Protein Alpha Inhibiting Activity Polypept 96T
E13721h Human G Protein Alpha Inhibiting Activity Polypept 96T
CSB-E13204h Human melanoma-inhibiting activity protein (MIA) ELISA Kit SpeciesHuman 96T
pro-940 Recombinant Human Guanine Nucleotide Binding Protein Alpha Inhibiting Activity 1 2
pro-940 Recombinant Human Guanine Nucleotide Binding Protein Alpha Inhibiting Activity 1 1mg
pro-940 Recombinant Human Guanine Nucleotide Binding Protein Alpha Inhibiting Activity 1 10
RPR-940 Recombinant Human Guanine Nucleotide Binding Protein Alpha Inhibiting Activity 1 2
RPR-074 Recombinant Human Guanine Nucleotide Binding Protein Alpha Inhibiting Activity 3 2
K3011-1 P450 Demethylation Activity kit (2 plate) The Cytochrome P450 Activity kit is designed to measure the enzymatic activity of demethylation processes carried out by Cytochrome P450. The unique feature o 192 rxns
SDS05 TALEN vector construction plus activity determination (one pair activity proved)
27-178 The function of this protein is binding , oxidoreductase activity ,and transcription repressor activity. 0.05 mg
DT1001 Human tPA Activity & ELISA Duro Kit (Measure activity & protein concentration in one assay) 96 well plate
RPR-310 Recombinant Human Guanine Nucleotide Binding Protein-G Alpha Inhibiting Activity Polypeptide 2 5
ARP54632_P050 GNAI2(guanine nucleotide binding protein, alpha inhibiting activity polypeptide 2) 50 µg
pro-1074 Recombinant Human Guanine Nucleotide Binding Protein Alpha Inhibiting Activity 3 2
pro-1074 Recombinant Human Guanine Nucleotide Binding Protein Alpha Inhibiting Activity 3 1mg
ARP54631_P050 GNAI2(guanine nucleotide binding protein, alpha inhibiting activity polypeptide 2) 50 µg
ARP54630_P050 GNAI1(guanine nucleotide binding protein, alpha inhibiting activity polypeptide 1) 50 µg
ARP54630_P050 GNAI1(guanine nucleotide binding protein, alpha inhibiting activity polypeptide 1) 50 µg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur